Home
>
Reference Standards>HIV>
>
N2-(1-Oxodecyl)-L-arginyl-L-valyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-(chloroacetyl)butyl]-L-lysin
For research use only. Not for therapeutic Use.
N2-(1-Oxodecyl)-L-arginyl-L-valyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-(chloroacetyl)butyl]-L-lysin(Cat No.:R062090)is a synthetic peptide derivative designed for research applications, particularly in the study of protease inhibition and enzyme-substrate interactions. Its unique structure, incorporating a chloroacetyl moiety, suggests potential utility as a covalent inhibitor in biochemical assays. The compound’s arginyl and lysyl residues facilitate interactions with active sites of target proteins, making it valuable in exploring proteolytic mechanisms and therapeutic drug design. With its well-defined chemical properties, it serves as a critical tool for advancing research in enzymology and pharmacological studies.
Catalog Number | R062090 |
CAS Number | 150113-99-8 |
Synonyms | (S)-N2-(1-Oxodecyl)-L-arginyl-L-valyl-N-[4-[(aminoiminomethyl)amino]-1-(chloroacetyl)butyl]-L-lysinamide; 1: PN: WO2005112971 PAGE: 27 claimed protein; Furin Inhibitor I; N-((6S,9S,12S,15S)-1,20-Diamino-9-(4-aminobutyl)-6-(2-chloroacetyl)-1,20-diimin |
Molecular Formula | C34H66ClN11O5 |
Purity | ≥95% |
Target | HIV |
Solubility | Soluble to 1 mg/ml in sterile water |
Storage | Store at -20C |
IUPAC Name | N-[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(3S)-1-chloro-6-(diaminomethylideneamino)-2-oxohexan-3-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]decanamide |
InChI | InChI=1S/C34H66ClN11O5/c1-4-5-6-7-8-9-10-18-28(48)43-25(17-14-21-42-34(39)40)31(50)46-29(23(2)3)32(51)45-26(15-11-12-19-36)30(49)44-24(27(47)22-35)16-13-20-41-33(37)38/h23-26,29H,4-22,36H2,1-3H3,(H,43,48)(H,44,49)(H,45,51)(H,46,50)(H4,37,38,41)(H4,39,40,42)/t24-,25-,26-,29-/m0/s1 |
InChIKey | NHBJTTGFHCHQHS-VZTVMPNDSA-N |
SMILES | CCCCCCCCCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)CCl |